Skip to main content
Livermore
Livermore
ZHEN

Qube Research & Technologies Ltd

SEC CIK
0001729829
Latest filing
Aug 14, 2026

NVS holding history

Novartis AG in every 13F filed by Qube Research & Technologies Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NVS overviewAll 13F holders of NVSFull Q2 2026 holdings

Shares (Q2 2026)
43,740
Value
$6.85M
% of portfolio
<0.1%
Quarters held
19
Since Q1 2021
Holdings of NVS by Qube Research & Technologies Ltd, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202643,740$6.85M<0.1%−129,397−74.7%ReducedHolders
Q1 2026173,137$26.4M<0.1%+54,510+46.0%AddedHolders
Q4 2025118,627$16.4M<0.1%−70,840−37.4%ReducedHolders
Q3 2025189,467$24.3M<0.1%+189,467NewHolders
Q2 20250$00.0%−39,723−100.0%Sold outHolders
Q1 202539,723$4.43M<0.1%−594,851−93.7%ReducedHolders
Q4 2024634,574$61.8M0.1%+476,420+301.2%AddedHolders
Q3 2024158,154$18.2M<0.1%−17,329−9.9%ReducedHolders
Q2 2024175,483$18.7M<0.1%−554,229−76.0%ReducedHolders
Q1 2024729,712$70.6M0.1%+385,402+111.9%AddedHolders
Q4 2023344,310$34.8M0.1%+226,515+192.3%AddedHolders
Q3 2023117,795$12.0M<0.1%−87,989−42.8%ReducedHolders
Q2 2023205,784$20.8M0.1%+205,784NewHolders
Q1 20230$00.0%−165,124−100.0%Sold outHolders
Q4 2022165,124$15.0M0.1%+49,736+43.1%AddedHolders
Q3 2022115,388$8.77M0.1%−70,151−37.8%ReducedHolders
Q2 2022185,539$15.7M0.1%+141,326+319.6%AddedHolders
Q1 202244,213$3.88M<0.1%+44,213NewHolders
Q4 20210$00.0%−103,144−100.0%Sold outHolders
Q3 2021103,144$8.44M0.1%−1,080−1.0%ReducedHolders
Q2 2021104,224$9.51M0.1%+101,518+3,751.6%AddedHolders
Q1 20212,706$231.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.